Meeting
2019 ASCO Quality Care Symposium
Characteristics, treatment patterns, and survival from three cohorts of advanced or metastatic cancer patients using health care claims data in the United States.
Authors
Daniel C Beachler
Safety and Epidemiology, HealthCore, Inc., Wilmington, DE
Daniel C Beachler, Francois-Xavier Lamy, Leo J Russo, Stephan Lanes, Jade Dinh, Devon H Taylor, Ruihua Yin, Aziza Jamal-Allial, Patrice Verpillat
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Access to Care
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 129)
DOI
10.1200/JCO.2019.37.27_suppl.129
Abstract #
129
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of hypofractionated radiation therapy to augment immune response in patients with metastatic gastrointestinal malignancies progressing on immune therapy (ARM-GI).
First Author: Hewitt Chang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma.
First Author: Alina Pascale
Poster
2023 ASCO Annual Meeting
Time-dependent efficacy of immune checkpoint inhibitors in the treatment of metastatic cancers: A meta-analysis.
First Author: Thierry Landre
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla